Myocardial infarction due to coronary thrombosis is a critical medical condition characterized by the formation of a blood clot within the coronary arteries, impeding blood flow to the heart muscle. This obstruction poses a significant threat, often resulting in severe consequences if not promptly addressed. The coronary arteries play a pivotal role in nourishing the heart with oxygen and nutrients, ensuring its optimal function. However, the occurrence of a thrombus within these arteries disrupts this essential blood flow, leading to an insufficient supply of oxygen to the heart. This oxygen deprivation can inflict damage to the heart muscle, culminating in a heart attack. Various risk factors contribute to the development of coronary thrombosis, including atherosclerosis, marked by the accumulation of plaque in the arteries, high blood pressure, and smoking. The interplay of these factors increases the likelihood of thrombus formation and exacerbates the potential for adverse cardiac events. Swift medical intervention is imperative in the face of coronary thrombosis. Treatment modalities include the administration of clot-dissolving medications and invasive procedures like angioplasty, both aimed at restoring normal blood flow and preventing further harm to the heart.
Title : Investigating the long-term follow up of atrial septal device closures in wales and england: A comparative analysis with major adverse cardiovascular Events (MACE)
Meera Gopinath, Cardiff University Medical school, United Kingdom
Title : An adult case of polysplenia syndrome associated with sinus node dysfunction
Apoorva Tripathi, Oxford University Hospitals, United Kingdom
Title : A unique cell-driven phenomenon in the heart and the promising future of the innovative translational tools to manage cardiac self-renewal and regeneration
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Yasser’s criterion of inferior ST-segment discrepancy deviations in AF with aberrancy and Sgarbosa criteria - a new cardiovascular discovery and management - a case report
Yasser Mohammed Hassanain Elsayed, Egyptian Ministry of Health, Egypt